Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuying Tan

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
In Vivo (Athens, Greece)|November 4, 2020
Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) ModelHye In Lim, Jun Yamamoto, Qinhong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2024
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian CancerYinu Wang, Xiaolei Situ, Horacio Cardenas, et al.
In Vivo (Athens, Greece)|May 2, 2020
Oral Recombinant Methioninase Prevents Nonalcoholic Fatty Liver Disease in Mice on a High Fat DietYoshihiko Tashiro, Qinghong Han, Yuying Tan, et al.
Cell Cycle (Georgetown, Tex.)|April 7, 2018
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancerKei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
In Vivo (Athens, Greece)|May 2, 2020
Oral Recombinant Methioninase Inhibits Diabetes Onset in Mice on a High-fat DietYoshihiko Tashiro, Qinghong Han, Yuying Tan, et al.
Cancer Research|August 18, 2004
Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphateZhijian Yang, Xinghua Sun, Shukuan Li, et al.
Biochemical and Biophysical Research Communications|December 17, 2019
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Qinghong Han, Kentaro Miyake, et al.
Nature Methods|January 17, 2025
Label-free nanoscopy of cell metabolism by ultrasensitive reweighted visible stimulated Raman scatteringHaonan Lin, Scott Seitz, Yuying Tan, et al.
Cancer Research|November 11, 2020
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to FerroptosisYinu Wang, Guangyuan Zhao, Salvatore Condello, et al.
Cancer Chemotherapy and Pharmacology|November 10, 2019
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Norihiko Sugisawa, Jun Yamamoto, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
In Vivo (Athens, Greece)|November 4, 2020
Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) ModelHye In Lim, Jun Yamamoto, Qinhong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2024
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian CancerYinu Wang, Xiaolei Situ, Horacio Cardenas, et al.
In Vivo (Athens, Greece)|May 2, 2020
Oral Recombinant Methioninase Prevents Nonalcoholic Fatty Liver Disease in Mice on a High Fat DietYoshihiko Tashiro, Qinghong Han, Yuying Tan, et al.
Cell Cycle (Georgetown, Tex.)|April 7, 2018
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancerKei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
In Vivo (Athens, Greece)|May 2, 2020
Oral Recombinant Methioninase Inhibits Diabetes Onset in Mice on a High-fat DietYoshihiko Tashiro, Qinghong Han, Yuying Tan, et al.
Cancer Research|August 18, 2004
Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphateZhijian Yang, Xinghua Sun, Shukuan Li, et al.
Biochemical and Biophysical Research Communications|December 17, 2019
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Qinghong Han, Kentaro Miyake, et al.
Nature Methods|January 17, 2025
Label-free nanoscopy of cell metabolism by ultrasensitive reweighted visible stimulated Raman scatteringHaonan Lin, Scott Seitz, Yuying Tan, et al.
Cancer Research|November 11, 2020
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to FerroptosisYinu Wang, Guangyuan Zhao, Salvatore Condello, et al.
Cancer Chemotherapy and Pharmacology|November 10, 2019
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Norihiko Sugisawa, Jun Yamamoto, et al.
Pageof 10